Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided injection comparison for tennis elbow
ACTRN12614000398606Phase 4Completed
- Sponsor
- The University of Queensland
- Start
- Jan 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of betamethasone, autologous blood and 10XB101 in Lateral Epicondylitis (LET) (3 arms), sponsored by The University of Queensland. Primary endpoint: Global Rating of Change scale at 26 weeks. Started Jan 2012; status: completed.
02
Drugs
betamethasoneautologous blood10XB101
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on ACTRN12614000398606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000398606.